MiniMed Group, Inc. (MMED) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2026, MiniMed reported revenue of $3.10B. Net income was -$333.0M (a -10.7% net margin), or -$1.30 per diluted share. Gross margin was 54.2% and operating margin was -6.1%. Operating activities generated -$197.0M of cash, leaving -$420.0M of free cash flow. At fiscal year end, MiniMed held $4.63B in total assets against $1.02B in total liabilities, including $298.0M of cash and equivalents.
Open the full interactive MiniMed financials → Quarterly statements, key ratios, valuation history and price charts.
MiniMed Key Stats
| Share Price | $18.40 |
|---|---|
| Market Cap | $4.72B |
| 52-Week Range | $10.80 – $23.84 |
| Shares Outstanding | 252.8 million (basic, 2026 Q3) |
MiniMed Income Statement
| FY 2026 | |
|---|---|
| Revenue | $3.10B |
| Cost of Goods Sold | $1.42B |
| Gross Profit | $1.68B |
| Operating Income | -$190.0M |
| Pre-Tax Income | -$189.0M |
| Income Tax | $128.0M |
| Net Income | -$333.0M |
| Diluted EPS | -$1.30 |
MiniMed Quarterly Results
| 2026 Q2 | 2026 Q3 | |
|---|---|---|
| Revenue | $843.0M | $790.0M |
| Net Income | $0 | -$119.0M |
| Diluted EPS | — | -$0.47 |
MiniMed Balance Sheet
| FY 2026 | |
|---|---|
| Cash & Equivalents | $298.0M |
| Current Assets | $1.35B |
| Total Assets | $4.63B |
| Current Liabilities | $702.0M |
| Total Liabilities | $1.02B |
| Shareholders' Equity | $3.61B |
MiniMed Cash Flow Statement
| FY 2026 | |
|---|---|
| Cash From Operations | -$197.0M |
| Cash From Investing | -$233.0M |
| Cash From Financing | $716.0M |
| Free Cash Flow | -$420.0M |
Figures from MiniMed's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full MiniMed financials page for every line item.
MiniMed Company Profile
| Ticker | MMED |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Northridge, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer |
| SEC CIK | 0002062583 |
Frequently Asked Questions
What was MiniMed's revenue in fiscal 2026?
MiniMed (MMED) reported revenue of $3.10B for fiscal 2026.
What was MiniMed's net income in fiscal 2026?
MiniMed reported net income of -$333.0M for fiscal 2026.
What was MiniMed's earnings per share (EPS) in fiscal 2026?
MiniMed's diluted EPS was -$1.30 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did MiniMed generate in fiscal 2026?
MiniMed generated -$420.0M of free cash flow in fiscal 2026.
What was MiniMed's revenue last quarter?
In its most recent reported quarter (2026 Q3), MiniMed reported revenue of $790.0M.
How many shares of MiniMed are outstanding?
MiniMed reported a weighted average of 252.8 million basic shares outstanding in 2026 Q3.
What is MiniMed's market cap?
Based on its latest closing price, MiniMed (MMED) has a market capitalization of about $4.72B.
When does MiniMed's fiscal year end?
MiniMed's fiscal year end, as registered with the SEC, is December 31.
Where is MiniMed headquartered?
MiniMed lists its business address in Northridge, California in its SEC filings.